Literature DB >> 17667989

Atheroembolic renal disease: a silent masquerader.

B V Mittal1, M P Alexander, H G Rennke, A K Singh.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17667989     DOI： 10.1038/sj.ki.5002433

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  5 in total

Review 1.  Atherosclerotic-nephropathy: an updated narrative review.

Authors:  Mariadelina Simeoni; Silvio Borrelli; Carlo Garofalo; Giorgio Fuiano; Ciro Esposito; Alessandro Comi; Michele Provenzano
Journal:  J Nephrol       Date:  2020-04-08       Impact factor: 3.902

2.  Cholesterol-crystal embolism presenting with delayed graft function and impaired long-term function in renal transplant recipients: two case reports.

Authors:  Rainer U Pliquett; Aida Asbe-Vollkopf; Ernst H Scheuermann; Elisabeth Gröne; Michael Probst; Helmut Geiger; Ingeborg A Hauser
Journal:  J Med Case Rep       Date:  2009-03-26

Review 3.  Diabetic Kidney Disease: A Syndrome Rather Than a Single Disease.

Authors:  Giorgina B Piccoli; Giorgio Grassi; Gianfranca Cabiddu; Marta Nazha; Simona Roggero; Irene Capizzi; Agostino De Pascale; Adriano M Priola; Cristina Di Vico; Stefania Maxia; Valentina Loi; Anna M Asunis; Antonello Pani; Andrea Veltri
Journal:  Rev Diabet Stud       Date:  2015-08-10

4.  A Study of Relationship of Atheroembolic Risk Factors with Postoperative Recovery in Renal Function after Partial Nephrectomy in Patients Staged T1-2 Renal Cell Carcinoma during Median 4-Year Follow-up.

Authors:  Sung Han Kim; Kyung Min Kang; Ami Yu; Jung Hoon Lee; Byung Ho Nam; Eun Sik Lee
Journal:  Cancer Res Treat       Date:  2015-04-15       Impact factor: 4.679

Review 5.  Cholesterol Crystal Embolism and Chronic Kidney Disease.

Authors:  Xuezhu Li; George Bayliss; Shougang Zhuang
Journal:  Int J Mol Sci       Date:  2017-05-24       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.